Physician profile
Hannah Pham
NPI 1881157212
$3,719.72
in general payments reported to CMS, 2019-2025
24 companies · $1,787 in 2025
The $1,787 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,933 · 2025: $1,787.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,719.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,118.91 | 2024-2025 | Ams 700, Spaceoar Vue System - 10ml, Greenlight Xps |
| Medtronic, INC. | $613.42 | 2024-2025 | Interstim |
| Procept Biorobotics Corporation | $440.16 | 2024-2025 | Aquabeam System |
| Axonics, INC. | $222.44 | 2024 | Axonics |
| Baxter Healthcare | $131.96 | 2024 | Perclot |
| Tolmar, INC. | $104.06 | 2025 | Jatenzo, Eligard |
| Urogen Pharma, INC. | $99.52 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $97.86 | 2025 | Provenge |
| Endo USA, INC. | $97.26 | 2024-2025 | Aveed, Xiaflex |
| Janssen Biotech, INC. | $93.81 | 2024-2025 | Erleada, Akeega |
| Progenics Pharmaceuticals, INC. | $83.18 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $79.84 | 2025 | |
| Sumitomo Pharma America, INC. | $77.69 | 2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $70.19 | 2024-2025 | Xyosted |
| Pfizer INC. | $64.97 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $63.48 | 2024-2025 | Prolaris |
| Agiliti Surgical, INC. | $59.14 | 2025 | Koelis Trinity Mri/US Fusion, Boston Scientific Lumenis Pulse 120h Holmium Laser W/ Moses Technology, Sonablate Hifu |
| Abbvie INC. | $44.75 | 2024-2025 | |
| Teleflex LLC | $43.12 | 2024 | Solesta |
| Ambu INC. | $29.16 | 2025 | |
| Immunitybio, INC. | $25.11 | 2025 | |
| Merck Sharp & Dohme LLC | $23.43 | 2024 | Keytruda |
| Astellas Pharma US INC | $19.27 | 2024 | Xtandi |
| Azurity Pharmaceuticals, INC. | $16.99 | 2025 | Azmiro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.